1 Market Overview
1.1 Product Overview and Scope of Angiogenesis Therapeutic Agent
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Angiogenesis Therapeutic Agent Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Myopic Choroidal Neovascularization
1.3.3 Macular Edema
1.3.4 Diabetic Retinopathy
1.3.5 Macular Degeneration
1.4 Market Analysis by Application
1.4.1 Overview: Global Angiogenesis Therapeutic Agent Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies
1.4.4 Hospital Pharmacies
1.5 Global Angiogenesis Therapeutic Agent Market Size & Forecast
1.5.1 Global Angiogenesis Therapeutic Agent Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Angiogenesis Therapeutic Agent Sales Quantity (2018-2029)
1.5.3 Global Angiogenesis Therapeutic Agent Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Gilead Sciences, Inc.
2.1.1 Gilead Sciences, Inc. Details
2.1.2 Gilead Sciences, Inc. Major Business
2.1.3 Gilead Sciences, Inc. Angiogenesis Therapeutic Agent Product and Services
2.1.4 Gilead Sciences, Inc. Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Gilead Sciences, Inc. Recent Developments/Updates
2.2 Eyetech Inc.
2.2.1 Eyetech Inc. Details
2.2.2 Eyetech Inc. Major Business
2.2.3 Eyetech Inc. Angiogenesis Therapeutic Agent Product and Services
2.2.4 Eyetech Inc. Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Eyetech Inc. Recent Developments/Updates
2.3 Becton, Dickinson and Company
2.3.1 Becton, Dickinson and Company Details
2.3.2 Becton, Dickinson and Company Major Business
2.3.3 Becton, Dickinson and Company Angiogenesis Therapeutic Agent Product and Services
2.3.4 Becton, Dickinson and Company Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Becton, Dickinson and Company Recent Developments/Updates
2.4 Regeneron Pharmaceuticals, Inc.
2.4.1 Regeneron Pharmaceuticals, Inc. Details
2.4.2 Regeneron Pharmaceuticals, Inc. Major Business
2.4.3 Regeneron Pharmaceuticals, Inc. Angiogenesis Therapeutic Agent Product and Services
2.4.4 Regeneron Pharmaceuticals, Inc. Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Regeneron Pharmaceuticals, Inc. Recent Developments/Updates
2.5 Genentech, Inc.
2.5.1 Genentech, Inc. Details
2.5.2 Genentech, Inc. Major Business
2.5.3 Genentech, Inc. Angiogenesis Therapeutic Agent Product and Services
2.5.4 Genentech, Inc. Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Genentech, Inc. Recent Developments/Updates
2.6 Novartis AG
2.6.1 Novartis AG Details
2.6.2 Novartis AG Major Business
2.6.3 Novartis AG Angiogenesis Therapeutic Agent Product and Services
2.6.4 Novartis AG Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novartis AG Recent Developments/Updates
2.7 Allergan plc
2.7.1 Allergan plc Details
2.7.2 Allergan plc Major Business
2.7.3 Allergan plc Angiogenesis Therapeutic Agent Product and Services
2.7.4 Allergan plc Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Allergan plc Recent Developments/Updates
2.8 Bayer AG
2.8.1 Bayer AG Details
2.8.2 Bayer AG Major Business
2.8.3 Bayer AG Angiogenesis Therapeutic Agent Product and Services
2.8.4 Bayer AG Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bayer AG Recent Developments/Updates
2.9 Santen Pharmaceutical Co., Ltd.
2.9.1 Santen Pharmaceutical Co., Ltd. Details
2.9.2 Santen Pharmaceutical Co., Ltd. Major Business
2.9.3 Santen Pharmaceutical Co., Ltd. Angiogenesis Therapeutic Agent Product and Services
2.9.4 Santen Pharmaceutical Co., Ltd. Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Santen Pharmaceutical Co., Ltd. Recent Developments/Updates
2.10 Shanghai Pharmaceuticals
2.10.1 Shanghai Pharmaceuticals Details
2.10.2 Shanghai Pharmaceuticals Major Business
2.10.3 Shanghai Pharmaceuticals Angiogenesis Therapeutic Agent Product and Services
2.10.4 Shanghai Pharmaceuticals Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Shanghai Pharmaceuticals Recent Developments/Updates
2.11 Johnson & Johnson
2.11.1 Johnson & Johnson Details
2.11.2 Johnson & Johnson Major Business
2.11.3 Johnson & Johnson Angiogenesis Therapeutic Agent Product and Services
2.11.4 Johnson & Johnson Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Johnson & Johnson Recent Developments/Updates
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Angiogenesis Therapeutic Agent Product and Services
2.12.4 Pfizer Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Pfizer Recent Developments/Updates
2.13 Sun Pharma
2.13.1 Sun Pharma Details
2.13.2 Sun Pharma Major Business
2.13.3 Sun Pharma Angiogenesis Therapeutic Agent Product and Services
2.13.4 Sun Pharma Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Sun Pharma Recent Developments/Updates
2.14 Otsuka Pharmaceutical Co. Ltd
2.14.1 Otsuka Pharmaceutical Co. Ltd Details
2.14.2 Otsuka Pharmaceutical Co. Ltd Major Business
2.14.3 Otsuka Pharmaceutical Co. Ltd Angiogenesis Therapeutic Agent Product and Services
2.14.4 Otsuka Pharmaceutical Co. Ltd Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Otsuka Pharmaceutical Co. Ltd Recent Developments/Updates
2.15 Daiichi Sankyo
2.15.1 Daiichi Sankyo Details
2.15.2 Daiichi Sankyo Major Business
2.15.3 Daiichi Sankyo Angiogenesis Therapeutic Agent Product and Services
2.15.4 Daiichi Sankyo Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Daiichi Sankyo Recent Developments/Updates
2.16 ERC Labs
2.16.1 ERC Labs Details
2.16.2 ERC Labs Major Business
2.16.3 ERC Labs Angiogenesis Therapeutic Agent Product and Services
2.16.4 ERC Labs Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 ERC Labs Recent Developments/Updates
2.17 Medicom Health care
2.17.1 Medicom Health care Details
2.17.2 Medicom Health care Major Business
2.17.3 Medicom Health care Angiogenesis Therapeutic Agent Product and Services
2.17.4 Medicom Health care Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Medicom Health care Recent Developments/Updates
2.18 Implandata ophthalmic products GmbH
2.18.1 Implandata ophthalmic products GmbH Details
2.18.2 Implandata ophthalmic products GmbH Major Business
2.18.3 Implandata ophthalmic products GmbH Angiogenesis Therapeutic Agent Product and Services
2.18.4 Implandata ophthalmic products GmbH Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Implandata ophthalmic products GmbH Recent Developments/Updates
2.19 The Geuder Group, MORCHER GmbH
2.19.1 The Geuder Group, MORCHER GmbH Details
2.19.2 The Geuder Group, MORCHER GmbH Major Business
2.19.3 The Geuder Group, MORCHER GmbH Angiogenesis Therapeutic Agent Product and Services
2.19.4 The Geuder Group, MORCHER GmbH Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 The Geuder Group, MORCHER GmbH Recent Developments/Updates
2.20 Novamedika
2.20.1 Novamedika Details
2.20.2 Novamedika Major Business
2.20.3 Novamedika Angiogenesis Therapeutic Agent Product and Services
2.20.4 Novamedika Angiogenesis Therapeutic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Novamedika Recent Developments/Updates
3 Competitive Environment: Angiogenesis Therapeutic Agent by Manufacturer
3.1 Global Angiogenesis Therapeutic Agent Sales Quantity by Manufacturer (2018-2023)
3.2 Global Angiogenesis Therapeutic Agent Revenue by Manufacturer (2018-2023)
3.3 Global Angiogenesis Therapeutic Agent Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Angiogenesis Therapeutic Agent by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Angiogenesis Therapeutic Agent Manufacturer Market Share in 2022
3.4.2 Top 6 Angiogenesis Therapeutic Agent Manufacturer Market Share in 2022
3.5 Angiogenesis Therapeutic Agent Market: Overall Company Footprint Analysis
3.5.1 Angiogenesis Therapeutic Agent Market: Region Footprint
3.5.2 Angiogenesis Therapeutic Agent Market: Company Product Type Footprint
3.5.3 Angiogenesis Therapeutic Agent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Angiogenesis Therapeutic Agent Market Size by Region
4.1.1 Global Angiogenesis Therapeutic Agent Sales Quantity by Region (2018-2029)
4.1.2 Global Angiogenesis Therapeutic Agent Consumption Value by Region (2018-2029)
4.1.3 Global Angiogenesis Therapeutic Agent Average Price by Region (2018-2029)
4.2 North America Angiogenesis Therapeutic Agent Consumption Value (2018-2029)
4.3 Europe Angiogenesis Therapeutic Agent Consumption Value (2018-2029)
4.4 Asia-Pacific Angiogenesis Therapeutic Agent Consumption Value (2018-2029)
4.5 South America Angiogenesis Therapeutic Agent Consumption Value (2018-2029)
4.6 Middle East and Africa Angiogenesis Therapeutic Agent Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Angiogenesis Therapeutic Agent Sales Quantity by Type (2018-2029)
5.2 Global Angiogenesis Therapeutic Agent Consumption Value by Type (2018-2029)
5.3 Global Angiogenesis Therapeutic Agent Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Angiogenesis Therapeutic Agent Sales Quantity by Application (2018-2029)
6.2 Global Angiogenesis Therapeutic Agent Consumption Value by Application (2018-2029)
6.3 Global Angiogenesis Therapeutic Agent Average Price by Application (2018-2029)
7 North America
7.1 North America Angiogenesis Therapeutic Agent Sales Quantity by Type (2018-2029)
7.2 North America Angiogenesis Therapeutic Agent Sales Quantity by Application (2018-2029)
7.3 North America Angiogenesis Therapeutic Agent Market Size by Country
7.3.1 North America Angiogenesis Therapeutic Agent Sales Quantity by Country (2018-2029)
7.3.2 North America Angiogenesis Therapeutic Agent Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Angiogenesis Therapeutic Agent Sales Quantity by Type (2018-2029)
8.2 Europe Angiogenesis Therapeutic Agent Sales Quantity by Application (2018-2029)
8.3 Europe Angiogenesis Therapeutic Agent Market Size by Country
8.3.1 Europe Angiogenesis Therapeutic Agent Sales Quantity by Country (2018-2029)
8.3.2 Europe Angiogenesis Therapeutic Agent Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Angiogenesis Therapeutic Agent Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Angiogenesis Therapeutic Agent Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Angiogenesis Therapeutic Agent Market Size by Region
9.3.1 Asia-Pacific Angiogenesis Therapeutic Agent Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Angiogenesis Therapeutic Agent Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Angiogenesis Therapeutic Agent Sales Quantity by Type (2018-2029)
10.2 South America Angiogenesis Therapeutic Agent Sales Quantity by Application (2018-2029)
10.3 South America Angiogenesis Therapeutic Agent Market Size by Country
10.3.1 South America Angiogenesis Therapeutic Agent Sales Quantity by Country (2018-2029)
10.3.2 South America Angiogenesis Therapeutic Agent Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Angiogenesis Therapeutic Agent Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Angiogenesis Therapeutic Agent Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Angiogenesis Therapeutic Agent Market Size by Country
11.3.1 Middle East & Africa Angiogenesis Therapeutic Agent Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Angiogenesis Therapeutic Agent Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Angiogenesis Therapeutic Agent Market Drivers
12.2 Angiogenesis Therapeutic Agent Market Restraints
12.3 Angiogenesis Therapeutic Agent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Angiogenesis Therapeutic Agent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Angiogenesis Therapeutic Agent
13.3 Angiogenesis Therapeutic Agent Production Process
13.4 Angiogenesis Therapeutic Agent Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Angiogenesis Therapeutic Agent Typical Distributors
14.3 Angiogenesis Therapeutic Agent Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Angiogenesis Therapeutic Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Angiogenesis Therapeutic Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Gilead Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Gilead Sciences, Inc. Major Business
Table 5. Gilead Sciences, Inc. Angiogenesis Therapeutic Agent Product and Services
Table 6. Gilead Sciences, Inc. Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Gilead Sciences, Inc. Recent Developments/Updates
Table 8. Eyetech Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Eyetech Inc. Major Business
Table 10. Eyetech Inc. Angiogenesis Therapeutic Agent Product and Services
Table 11. Eyetech Inc. Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Eyetech Inc. Recent Developments/Updates
Table 13. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 14. Becton, Dickinson and Company Major Business
Table 15. Becton, Dickinson and Company Angiogenesis Therapeutic Agent Product and Services
Table 16. Becton, Dickinson and Company Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Becton, Dickinson and Company Recent Developments/Updates
Table 18. Regeneron Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Regeneron Pharmaceuticals, Inc. Major Business
Table 20. Regeneron Pharmaceuticals, Inc. Angiogenesis Therapeutic Agent Product and Services
Table 21. Regeneron Pharmaceuticals, Inc. Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Regeneron Pharmaceuticals, Inc. Recent Developments/Updates
Table 23. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Genentech, Inc. Major Business
Table 25. Genentech, Inc. Angiogenesis Therapeutic Agent Product and Services
Table 26. Genentech, Inc. Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Genentech, Inc. Recent Developments/Updates
Table 28. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 29. Novartis AG Major Business
Table 30. Novartis AG Angiogenesis Therapeutic Agent Product and Services
Table 31. Novartis AG Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Novartis AG Recent Developments/Updates
Table 33. Allergan plc Basic Information, Manufacturing Base and Competitors
Table 34. Allergan plc Major Business
Table 35. Allergan plc Angiogenesis Therapeutic Agent Product and Services
Table 36. Allergan plc Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Allergan plc Recent Developments/Updates
Table 38. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 39. Bayer AG Major Business
Table 40. Bayer AG Angiogenesis Therapeutic Agent Product and Services
Table 41. Bayer AG Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bayer AG Recent Developments/Updates
Table 43. Santen Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Santen Pharmaceutical Co., Ltd. Major Business
Table 45. Santen Pharmaceutical Co., Ltd. Angiogenesis Therapeutic Agent Product and Services
Table 46. Santen Pharmaceutical Co., Ltd. Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Santen Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 48. Shanghai Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Shanghai Pharmaceuticals Major Business
Table 50. Shanghai Pharmaceuticals Angiogenesis Therapeutic Agent Product and Services
Table 51. Shanghai Pharmaceuticals Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Shanghai Pharmaceuticals Recent Developments/Updates
Table 53. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 54. Johnson & Johnson Major Business
Table 55. Johnson & Johnson Angiogenesis Therapeutic Agent Product and Services
Table 56. Johnson & Johnson Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Johnson & Johnson Recent Developments/Updates
Table 58. Pfizer Basic Information, Manufacturing Base and Competitors
Table 59. Pfizer Major Business
Table 60. Pfizer Angiogenesis Therapeutic Agent Product and Services
Table 61. Pfizer Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Pfizer Recent Developments/Updates
Table 63. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 64. Sun Pharma Major Business
Table 65. Sun Pharma Angiogenesis Therapeutic Agent Product and Services
Table 66. Sun Pharma Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Sun Pharma Recent Developments/Updates
Table 68. Otsuka Pharmaceutical Co. Ltd Basic Information, Manufacturing Base and Competitors
Table 69. Otsuka Pharmaceutical Co. Ltd Major Business
Table 70. Otsuka Pharmaceutical Co. Ltd Angiogenesis Therapeutic Agent Product and Services
Table 71. Otsuka Pharmaceutical Co. Ltd Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Otsuka Pharmaceutical Co. Ltd Recent Developments/Updates
Table 73. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 74. Daiichi Sankyo Major Business
Table 75. Daiichi Sankyo Angiogenesis Therapeutic Agent Product and Services
Table 76. Daiichi Sankyo Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Daiichi Sankyo Recent Developments/Updates
Table 78. ERC Labs Basic Information, Manufacturing Base and Competitors
Table 79. ERC Labs Major Business
Table 80. ERC Labs Angiogenesis Therapeutic Agent Product and Services
Table 81. ERC Labs Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. ERC Labs Recent Developments/Updates
Table 83. Medicom Health care Basic Information, Manufacturing Base and Competitors
Table 84. Medicom Health care Major Business
Table 85. Medicom Health care Angiogenesis Therapeutic Agent Product and Services
Table 86. Medicom Health care Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Medicom Health care Recent Developments/Updates
Table 88. Implandata ophthalmic products GmbH Basic Information, Manufacturing Base and Competitors
Table 89. Implandata ophthalmic products GmbH Major Business
Table 90. Implandata ophthalmic products GmbH Angiogenesis Therapeutic Agent Product and Services
Table 91. Implandata ophthalmic products GmbH Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Implandata ophthalmic products GmbH Recent Developments/Updates
Table 93. The Geuder Group, MORCHER GmbH Basic Information, Manufacturing Base and Competitors
Table 94. The Geuder Group, MORCHER GmbH Major Business
Table 95. The Geuder Group, MORCHER GmbH Angiogenesis Therapeutic Agent Product and Services
Table 96. The Geuder Group, MORCHER GmbH Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. The Geuder Group, MORCHER GmbH Recent Developments/Updates
Table 98. Novamedika Basic Information, Manufacturing Base and Competitors
Table 99. Novamedika Major Business
Table 100. Novamedika Angiogenesis Therapeutic Agent Product and Services
Table 101. Novamedika Angiogenesis Therapeutic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Novamedika Recent Developments/Updates
Table 103. Global Angiogenesis Therapeutic Agent Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 104. Global Angiogenesis Therapeutic Agent Revenue by Manufacturer (2018-2023) & (USD Million)
Table 105. Global Angiogenesis Therapeutic Agent Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 106. Market Position of Manufacturers in Angiogenesis Therapeutic Agent, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 107. Head Office and Angiogenesis Therapeutic Agent Production Site of Key Manufacturer
Table 108. Angiogenesis Therapeutic Agent Market: Company Product Type Footprint
Table 109. Angiogenesis Therapeutic Agent Market: Company Product Application Footprint
Table 110. Angiogenesis Therapeutic Agent New Market Entrants and Barriers to Market Entry
Table 111. Angiogenesis Therapeutic Agent Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Angiogenesis Therapeutic Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 113. Global Angiogenesis Therapeutic Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 114. Global Angiogenesis Therapeutic Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 115. Global Angiogenesis Therapeutic Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 116. Global Angiogenesis Therapeutic Agent Average Price by Region (2018-2023) & (US$/Unit)
Table 117. Global Angiogenesis Therapeutic Agent Average Price by Region (2024-2029) & (US$/Unit)
Table 118. Global Angiogenesis Therapeutic Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Global Angiogenesis Therapeutic Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Global Angiogenesis Therapeutic Agent Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Global Angiogenesis Therapeutic Agent Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Global Angiogenesis Therapeutic Agent Average Price by Type (2018-2023) & (US$/Unit)
Table 123. Global Angiogenesis Therapeutic Agent Average Price by Type (2024-2029) & (US$/Unit)
Table 124. Global Angiogenesis Therapeutic Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Global Angiogenesis Therapeutic Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Global Angiogenesis Therapeutic Agent Consumption Value by Application (2018-2023) & (USD Million)
Table 127. Global Angiogenesis Therapeutic Agent Consumption Value by Application (2024-2029) & (USD Million)
Table 128. Global Angiogenesis Therapeutic Agent Average Price by Application (2018-2023) & (US$/Unit)
Table 129. Global Angiogenesis Therapeutic Agent Average Price by Application (2024-2029) & (US$/Unit)
Table 130. North America Angiogenesis Therapeutic Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 131. North America Angiogenesis Therapeutic Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 132. North America Angiogenesis Therapeutic Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 133. North America Angiogenesis Therapeutic Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 134. North America Angiogenesis Therapeutic Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 135. North America Angiogenesis Therapeutic Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 136. North America Angiogenesis Therapeutic Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 137. North America Angiogenesis Therapeutic Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Europe Angiogenesis Therapeutic Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 139. Europe Angiogenesis Therapeutic Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 140. Europe Angiogenesis Therapeutic Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 141. Europe Angiogenesis Therapeutic Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 142. Europe Angiogenesis Therapeutic Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 143. Europe Angiogenesis Therapeutic Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 144. Europe Angiogenesis Therapeutic Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe Angiogenesis Therapeutic Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific Angiogenesis Therapeutic Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 147. Asia-Pacific Angiogenesis Therapeutic Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 148. Asia-Pacific Angiogenesis Therapeutic Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 149. Asia-Pacific Angiogenesis Therapeutic Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 150. Asia-Pacific Angiogenesis Therapeutic Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 151. Asia-Pacific Angiogenesis Therapeutic Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 152. Asia-Pacific Angiogenesis Therapeutic Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 153. Asia-Pacific Angiogenesis Therapeutic Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 154. South America Angiogenesis Therapeutic Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 155. South America Angiogenesis Therapeutic Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 156. South America Angiogenesis Therapeutic Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 157. South America Angiogenesis Therapeutic Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 158. South America Angiogenesis Therapeutic Agent Sales Quantity by Country (2018-2023) & (K Units)
Table 159. South America Angiogenesis Therapeutic Agent Sales Quantity by Country (2024-2029) & (K Units)
Table 160. South America Angiogenesis Therapeutic Agent Consumption Value by Country (2018-2023) & (USD Million)
Table 161. South America Angiogenesis Therapeutic Agent Consumption Value by Country (2024-2029) & (USD Million)
Table 162. Middle East & Africa Angiogenesis Therapeutic Agent Sales Quantity by Type (2018-2023) & (K Units)
Table 163. Middle East & Africa Angiogenesis Therapeutic Agent Sales Quantity by Type (2024-2029) & (K Units)
Table 164. Middle East & Africa Angiogenesis Therapeutic Agent Sales Quantity by Application (2018-2023) & (K Units)
Table 165. Middle East & Africa Angiogenesis Therapeutic Agent Sales Quantity by Application (2024-2029) & (K Units)
Table 166. Middle East & Africa Angiogenesis Therapeutic Agent Sales Quantity by Region (2018-2023) & (K Units)
Table 167. Middle East & Africa Angiogenesis Therapeutic Agent Sales Quantity by Region (2024-2029) & (K Units)
Table 168. Middle East & Africa Angiogenesis Therapeutic Agent Consumption Value by Region (2018-2023) & (USD Million)
Table 169. Middle East & Africa Angiogenesis Therapeutic Agent Consumption Value by Region (2024-2029) & (USD Million)
Table 170. Angiogenesis Therapeutic Agent Raw Material
Table 171. Key Manufacturers of Angiogenesis Therapeutic Agent Raw Materials
Table 172. Angiogenesis Therapeutic Agent Typical Distributors
Table 173. Angiogenesis Therapeutic Agent Typical Customers
List of Figures
Figure 1. Angiogenesis Therapeutic Agent Picture
Figure 2. Global Angiogenesis Therapeutic Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Angiogenesis Therapeutic Agent Consumption Value Market Share by Type in 2022
Figure 4. Myopic Choroidal Neovascularization Examples
Figure 5. Macular Edema Examples
Figure 6. Diabetic Retinopathy Examples
Figure 7. Macular Degeneration Examples
Figure 8. Global Angiogenesis Therapeutic Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Angiogenesis Therapeutic Agent Consumption Value Market Share by Application in 2022
Figure 10. Retail Pharmacies Examples
Figure 11. Online Pharmacies Examples
Figure 12. Hospital Pharmacies Examples
Figure 13. Global Angiogenesis Therapeutic Agent Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Angiogenesis Therapeutic Agent Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Angiogenesis Therapeutic Agent Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Angiogenesis Therapeutic Agent Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Angiogenesis Therapeutic Agent Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Angiogenesis Therapeutic Agent Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Angiogenesis Therapeutic Agent by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Angiogenesis Therapeutic Agent Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Angiogenesis Therapeutic Agent Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Angiogenesis Therapeutic Agent Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Angiogenesis Therapeutic Agent Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Angiogenesis Therapeutic Agent Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Angiogenesis Therapeutic Agent Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Angiogenesis Therapeutic Agent Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Angiogenesis Therapeutic Agent Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Angiogenesis Therapeutic Agent Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Angiogenesis Therapeutic Agent Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Angiogenesis Therapeutic Agent Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Angiogenesis Therapeutic Agent Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Angiogenesis Therapeutic Agent Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Angiogenesis Therapeutic Agent Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Angiogenesis Therapeutic Agent Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Angiogenesis Therapeutic Agent Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Angiogenesis Therapeutic Agent Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Angiogenesis Therapeutic Agent Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Angiogenesis Therapeutic Agent Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Angiogenesis Therapeutic Agent Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Angiogenesis Therapeutic Agent Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Angiogenesis Therapeutic Agent Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Angiogenesis Therapeutic Agent Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Angiogenesis Therapeutic Agent Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Angiogenesis Therapeutic Agent Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Angiogenesis Therapeutic Agent Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Angiogenesis Therapeutic Agent Consumption Value Market Share by Region (2018-2029)
Figure 55. China Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Angiogenesis Therapeutic Agent Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Angiogenesis Therapeutic Agent Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Angiogenesis Therapeutic Agent Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Angiogenesis Therapeutic Agent Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Angiogenesis Therapeutic Agent Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Angiogenesis Therapeutic Agent Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Angiogenesis Therapeutic Agent Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Angiogenesis Therapeutic Agent Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Angiogenesis Therapeutic Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Angiogenesis Therapeutic Agent Market Drivers
Figure 76. Angiogenesis Therapeutic Agent Market Restraints
Figure 77. Angiogenesis Therapeutic Agent Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Angiogenesis Therapeutic Agent in 2022
Figure 80. Manufacturing Process Analysis of Angiogenesis Therapeutic Agent
Figure 81. Angiogenesis Therapeutic Agent Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
